QUICKLINKS AND VIEW OPITONS
Use of Viagra-type drugs associated with 31% lower risk of death over 7.5 years
Posted by .(JavaScript must be enabled to view this email address)
Friday, March 17, 2017 1:42 pm Email this article
Men with Type 2 diabetes who were prescribed Viagra-type drugs for improving erections were 31% less likely to die than men of the same age who were not prescribed these drugs during an average follow-up of 7.5 years according to a recent study.
The risk of dying was 46% less after adjusting for age, kidney function, smoking status, prior stroke, hypertension, prior myocardial infarction, systolic blood pressure, use of statin, metformin, aspirin and β-blocker medication,
The study looked at the use of phosphodiesterase type-5 inhibitors which include sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) and avanafil (Stendra).
Subjects
Subjects: 5956 men, 40–89 years-old with type 2 diabetes from 42 general practices in Cheshire, UK
The study analyzed data from 5956 men aged 40– to 89-years-old diagnosed with type 2 diabetes between from 42 general practices in Cheshire, UK, and were followed for 7.5 years.
Reference
Anderson SG, Hutchings DC, Woodward M, Rahimi K, Rutter MK, Kirby M, Hackett G, Trafford AW, and Heald AH. Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. Heart, 2016 Nov 01; 102(21): 1750-1756.
Author’s Contact Info
Dr Simon G Anderson
Institute of Cardiovascular Sciences
University of Manchester
3.24 Core Technology Facility
46 Grafton Street
Manchester M13 9NT, UK
simon. .(JavaScript must be enabled to view this email address)
Articles on the same subject can be found here:
COMMENTS
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.